课题基金 / 基金详情

CONTINUOUS EXPOSURE ORAL PHENYLBUTYRATE 3 TIME DAILY SCHEDULE

CONTINUOUS EXPOSURE ORAL PHENYLBUTYRATE 3 TIME DAILY SCHEDULE
每日连续口服苯丁酸 3 次
批准号:
6263595
负责人:
JANE B ALAVI
金额:
$2.51万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-01 至 1999-11-30

项目摘要

项目成果

JANE B ALAVI的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
To determine the maximum tolerated dose of sodium phenyllbutyrate taken orally three times a day in patients with refractory CNS tumors until evidence of tumor progression. To describe the pharmacokinetic parameters of oral phenylbutyrate and to escalate the does of phenylbutyrate in an attempt to achieve plasma levels of 2-6 mmol/L while evaluating patient tolerability on the continuous oral exposure schedule. To seek preliminary evidence of therapeutic activity of phenylbutyrate when administered on this schedule to patients with refractory CNS tumors. To correlate any observed responses and toxicity with results of bioassays and tissue sampling for phenylbutyrate activity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PRE-IRRADIATION 9-AMINO-20(S)-CAMPTOTHECIN IN GLIOBLASTO
  • 批准号:
    6565778
  • 项目类别:
  • 资助金额:
    $12.41万
  • 财政年份:
    2001
  • 负责人:
    JANE B ALAVI
  • 依托单位:
UPCC7399: PYRAZOLACRIDINE IN ADULTS W NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME
  • 批准号:
    6565856
  • 项目类别:
  • 资助金额:
    $12.41万
  • 财政年份:
    2001
  • 负责人:
    JANE B ALAVI
  • 依托单位:
UPCC8399: ORAL PROCARBAZINE IN TREATMENT OF RECURRENT HIGH GRADE ASTROCYTOMA
  • 批准号:
    6565857
  • 项目类别:
  • 资助金额:
    $12.41万
  • 财政年份:
    2001
  • 负责人:
    JANE B ALAVI
  • 依托单位:
CONTINUOUS EXPOSURE ORAL PHENYLBUTYRATE 3 TIME DAILY SCHEDULE
  • 批准号:
    6565798
  • 项目类别:
  • 资助金额:
    $12.41万
  • 财政年份:
    2001
  • 负责人:
    JANE B ALAVI
  • 依托单位:
海外基金